Header Logo

Connection

Jorge Botas to alpha-Synuclein

Back to Details
This is a "connection" page, showing publications Jorge Botas has written about alpha-Synuclein.
Jorge Botas
Connection Strength
0.054
alpha-Synuclein
  1. Integration of cross-species multi-omics with in vivo experimental validation identifies Parkinson's disease therapeutic targets and novel risk factors within endolysosomal pathway subnetworks. Neurobiol Dis. 2026 05; 222:107364.
    View in: PubMed
    Score: 0.054
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.